Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-22,900
Closed -$1.07M 917
2025
Q1
$1.07M Buy
+22,900
New +$1.18M 0.17% 186
2024
Q2
Sell
-25,124
Closed -$1.01M 916
2024
Q1
$1.01M Buy
25,124
+19,400
+339% +$729K 0.2% 137
2023
Q4
$216K Sell
5,724
-14,200
-71% -$434K 0.04% 640
2023
Q3
$554K Buy
19,924
+10,900
+121% +$341K 0.11% 266
2023
Q2
$273K Sell
9,024
-2,853
-24% -$83.4K 0.05% 456
2023
Q1
$366K Buy
11,877
+4,700
+65% +$179K 0.05% 429
2022
Q4
$269K Sell
7,177
-1,823
-20% -$72.4K 0.02% 548
2022
Q3
$338K Buy
+9,000
New +$357K 0.02% 566

Other funds holding SNV

Versor Investments's SNV Position: Q2 2025 in Review

Versor Investments sold out of Synovus (SNV) in Q2 2025, closing a stake of 22,900 shares — an estimated $1.07M sold.

Versor Investments first reported a position in SNV in Q3 2022 and held it in 8 quarters. The position peaked at $1.07M in Q1 2025. 475 funds tracked by Wall St. Rank hold SNV as of Q2 2025.

  • Versor Investments reported no remaining Synovus position as of Q2 2025 after selling out during the quarter.
  • Versor Investments sold 22,900 Synovus shares in Q2 2025, an estimated $1.07M.
  • Versor Investments first reported a position in Synovus in Q3 2022 and held it in 8 quarters.
  • Versor Investments's Synovus position peaked at $1.07M in Q1 2025.
  • 475 funds tracked by Wall St. Rank held Synovus as of Q2 2025.

Based on Versor Investments's 13F filing for Q2 2025, filed 5 Aug 2025.